MAPT and Alzheimer disease: Consistent with all these properties, MEL administration in different AD animal models ameliorated oxidative stress, memory deficits, and Alzheimer’s-related neuropathology including amyloid load, tau hyperphosphorylation, and neurodegeneration [377,384,390,391,392].